XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses    
Research and development $ 12,930 $ 10,877
General and administrative 8,677 7,183
Total operating expenses 21,607 18,060
Other income (expense)    
Interest income 2,877 3,098
Other expense 0 (3)
Total other income 2,877 3,095
Net loss $ (18,730) $ (14,965)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.15) $ (0.12)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.15) $ (0.12)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 125,135,451 124,590,351
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 125,135,451 124,590,351